特殊ジェネリック薬のヨーロッパ市場2022-2027:産業動向、シェア、規模、成長、機会・予測

■ 英語タイトル:Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

調査会社IMARC社が発行したリサーチレポート(データ管理コード:IMARC22DV0313)■ 発行会社/調査会社:IMARC
■ 商品コード:IMARC22DV0313
■ 発行日:2022年10月
■ 調査対象地域:ヨーロッパ
■ 産業分野:医療
■ ページ数:108
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール
■ 販売価格オプション(消費税別)
Single UserUSD2,699 ⇒換算¥399,452見積依頼/購入/質問フォーム
Five UserUSD3,699 ⇒換算¥547,452見積依頼/購入/質問フォーム
EnterprisewideUSD4,699 ⇒換算¥695,452見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
IMARC社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[特殊ジェネリック薬のヨーロッパ市場2022-2027:産業動向、シェア、規模、成長、機会・予測]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

IMARC社によると、ヨーロッパの特殊ジェネリック薬市場規模は2021年に9.7百万ドルに達しました。今後、2027年には15.0百万ドルになり、2022年から2022年の間に年平均8.4%成長すると予想しています。本調査レポートでは、特殊ジェネリック薬のヨーロッパ市場について調査し、序論、調査範囲・手法、エグゼクティブサマリー、イントロダクション、投与経路別分析、疾患別分析、流通チャネル別分析、地域別分析、競争状況などを整理しています。

The Europe specialty generics market size reached US$ 16.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 28.1 Billion by 2027, exhibiting a growth rate (CAGR) of 8.86% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Specialty generics are classified as high-cost, high complexity and/or high touch generics. They are the generic versions of speciality branded drugs after they lose their patent protection. Specialty generics are used to treat complex diseases which may be chronic by nature and life-threatening like hepatitis C, cancer, rheumatoid arthritis, multiple sclerosis, etc.

Driven by factors such as an increasing aging population, changing lifestyles and a rising prevalence of chronic diseases, healthcare costs in Europe have increased significantly in recent years creating a huge burden on the government, healthcare providers and patients. Specialty generics are playing a major role in the region to reduce this cost burden as they are more cost-effective as compared to their branded versions. Unlike branded speciality drugs, specialty generics don’t require expensive and time-consuming research and development procedures. Additionally, they also don’t incur the same amount of marketing and promotional expenses, resulting in substantially lower costs. In addition to this, the patent expiration of several blockbuster specialty drugs is expected to expire in the coming years creating a positive impact on the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe specialty generics market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on route of administration, indication and distribution channel.

Breakup by Region:

Italy
Germany
France
United Kingdom
Spain
Rest of Europe

Breakup by Route of Administration:

Injectables
Oral
Others

Breakup by Indication:

Oncology
Autoimmune Diseases
Infectious Diseases
Others

Breakup by Distribution Channel:

Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies

Competitive Landscape:
The leading players in the European specialty generics industry have also been examined in the report.

Key Questions Answered in This Report:
How has the European specialty generics market performed so far and how will it perform in the coming years?
What is the breakup of the European specialty generics market based on the region?
What has been the impact of COVID-19 on the European specialty generics market?
What is the breakup of the European specialty generics market based on the route of administration?
What is the breakup of the European specialty generics market based on the indication?
What is the breakup of the European specialty generics market based on the distribution channel?
What are the various stages in the value chain of the European specialty generics industry?
What are the key driving factors and challenges in the European specialty generics market?
What is the structure of the European specialty generics industry and who are the key players?
What is the degree of competition in the European specialty generics market?

*** レポート目次(コンテンツ)***

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Specialty Generics Market: Introduction
4.1 What are Specialty Generic Drugs?
4.2 Types of Specialty Generics
5 Why are Specialty Generics So Lucrative?
6 Global Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Market Breakup by Route of Administration
6.4 Market Breakup by Indication
6.5 Market Breakup by Distribution Channel
6.6 Market Breakup by Region
6.7 Market Forecast
7 Europe Specialty Generics Market
7.1 Market Overview
7.2 Market Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Route of Administration
7.5 Market Breakup by Indication
7.6 Market Breakup by Distribution Channel
7.7 Market Breakup by Region
7.8 Market Forecast
7.9 SWOT Analysis
7.9.1 Overview
7.9.2 Strengths
7.9.3 Weaknesses
7.9.4 Opportunities
7.9.5 Threats
7.10 Value Chain Analysis
7.11 Porters Five Forces Analysis
7.11.1 Overview
7.11.2 Bargaining Power of Buyers
7.11.3 Bargaining Power of Suppliers
7.11.4 Degree of Competition
7.11.5 Threat of New Entrants
7.11.6 Threat of Substitutes
7.12 Key Market Drivers and Success Factors
8 Market Breakup by Route of Administration
8.1 Injectables
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Indication
9.1 Oncology
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Autoimmune Diseases
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Infectious Diseases
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Retail Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Specialty Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Hospital Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 Italy
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Germany
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 France
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 United Kingdom
11.4.1 Market Trends
11.4.2 Market Forecast
11.5 Spain
11.5.1 Market Trends
11.5.2 Market Forecast
11.6 Rest of Europe
11.6.1 Market Trends
11.6.2 Market Forecast
12 Competitive Landscape
12.1 Market Structure
12.2 Key Players
12.3 Profiles of Key Players

Figure 1: Europe: Specialty Generics Market: Major Drivers and Challenges
Figure 2: Global: Specialty Generics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2021
Figure 4: Global: Specialty Generics Market: Breakup by Indication (in %), 2021
Figure 5: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2021
Figure 6: Global: Specialty Generics Market: Breakup by Region (in %), 2021
Figure 7: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Europe: Specialty Generics Market: Sales Value (in Billion US$), 2016-2021
Figure 9: Europe: Specialty Generics Market: Breakup by Route of Administration (in %), 2021
Figure 10: Europe: Specialty Generics Market: Breakup by Indication (in %), 2021
Figure 11: Europe: Specialty Generics Market: Breakup by Distribution Channel (in %), 2021
Figure 12: Europe: Specialty Generics Market: Breakup by Region (in %), 2021
Figure 13: Europe: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 14: Europe: Specialty Generics Industry: SWOT Analysis
Figure 15: Europe: Specialty Generics Industry: Value Chain Analysis
Figure 16: Europe: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 17: Europe: Specialty Generics Market (Administration through Injectables): Sales Value (in Million US$), 2016 & 2021
Figure 18: Europe: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Europe: Specialty Generics Market (Oral Administration): Sales Value (in Million US$), 2016 & 2021
Figure 20: Europe: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Europe: Specialty Generics Market (Other Routes of Administration): Sales Value (in Million US$), 2016 & 2021
Figure 22: Europe: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Europe: Specialty Generics Market (Oncology): Sales Value (in Million US$), 2016 & 2021
Figure 24: Europe: Specialty Generics Market (Oncology) Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Europe: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Million US$), 2016 & 2021
Figure 26: Europe: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Europe: Specialty Generics Market (Infectious Diseases): Sales Value (in Million US$), 2016 & 2021
Figure 28: Europe: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Europe: Specialty Generics Market (Other Indications): Sales Value (in Million US$), 2016 & 2021
Figure 30: Europe: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Europe: Specialty Generics Market: Sales through Retail Pharmacies (in Million US$), 2016 & 2021
Figure 32: Europe: Specialty Generics Market Forecast: Sales through Retail Pharmacies (in Million US$), 2022-2027
Figure 33: Europe: Specialty Generics Market: Sales through Specialty Pharmacies (in Million US$), 2016 & 2021
Figure 34: Europe: Specialty Generics Market Forecast: Sales through Specialty Pharmacies (in Million US$), 2022-2027
Figure 35: Europe: Specialty Generics Market: Sales through Hospital Pharmacies (in Million US$), 2016 & 2021
Figure 36: Europe: Specialty Generics Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2022-2027
Figure 37: Italy: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Germany: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: France: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Spain: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Rest of Europe: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Rest of Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(IMARC22DV0313 )"特殊ジェネリック薬のヨーロッパ市場2022-2027:産業動向、シェア、規模、成長、機会・予測" (英文:Europe Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027)はIMARC社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。